Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/10/2012WO2012059482A1 Use of active pharmaceutical compounds for the treatment of central nervous system conditions
05/10/2012WO2012059447A1 A composition comprising s-[2-([[1-(2-ethylbutyl)-cyclohexyl]-carbonyl]amino)phenyl]2-methylpropanethioate and croscarmellose sodium
05/10/2012WO2012059443A2 Novel neurotrypsin inhibitors
05/10/2012WO2012059442A2 Neurotrypsin inhibitors
05/10/2012WO2012059432A1 N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
05/10/2012WO2012059431A1 Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
05/10/2012WO2012059416A1 Pharmaceutical combinations for the treatment of metabolic disorders
05/10/2012WO2012059371A1 Dihydrooxazol-2-amine derivatives
05/10/2012WO2012059286A1 Carotenoid compositions containing octenyl succinate anhydride-modified gum acacia
05/10/2012WO2012059232A1 Carbazole and carboline derivatives, and preparation and therapeutic applications thereof
05/10/2012WO2012059172A1 1h-pyrrolo[2,3-b]pyridine derivatives
05/10/2012WO2012059171A1 7-([1,2,3]triazol-4-yl)-pyrrolo[2,3-b]pyrazine derivatives
05/10/2012WO2012059158A1 Composition and drug containing omega-3 fatty acids, and a modulator
05/10/2012WO2012059090A1 Etacrynic acid for use in the treatment of food sensitivity disorders
05/10/2012WO2012059041A1 Novel 6-arylamino pyridone carboxamide as mek inhibitors
05/10/2012WO2012059012A1 Chinese medicine hair-blackening preparation and formula and preparation method therefor
05/10/2012WO2012059001A1 Imidazole derivatives and preparation method and use thereof
05/10/2012WO2012058993A1 Use of ambrisentan for preventing or alleviating cardiac function injury caused by hypoxia
05/10/2012WO2012058976A1 Diphosphonate compounds and preparation method and use thereof
05/10/2012WO2012058957A2 Polysaccharide extracts of epimedium, fractions thereof and uses thereof in vaccine adjuvants
05/10/2012WO2012058866A1 Benzamide derivative with anticancer activity and preparation method and use thereof
05/10/2012WO2012058795A1 Uses of unsaturated fatty acids for inhibiting virus replication and /or infection
05/10/2012WO2012058769A1 Method of treating mucosal inflammation
05/10/2012WO2012058763A1 Synthetic lethality in cancer
05/10/2012WO2012058719A1 Inhalable compositions
05/10/2012WO2012040389A3 Substituted bicyclic hcv inhibitors
05/10/2012WO2012037466A3 Methods and compositions for protection cells and tissues from computed tomography radiation
05/10/2012WO2012037410A9 Estrogen receptor modulators and uses thereof
05/10/2012WO2012037328A3 Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof
05/10/2012WO2012037155A3 Tyrosine kinase inhibitors
05/10/2012WO2012037000A4 Benzoyl peroxide composition, methods of making same, and pharmaceutical or cosmetic formulations comprising same, and uses thereof
05/10/2012WO2012036383A3 Use of a protein tyrosine kinase inhibitor for inducing the differentiation of mesenchymal stem cells into cardiogenic cells
05/10/2012WO2012033858A3 Benzoxaborole derivatives for treating bacterial infections
05/10/2012WO2012032533A3 Processes for the preparation of 4-{4-[5(s)-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl} morpholin-3-one
05/10/2012WO2012032360A3 Novel use
05/10/2012WO2012027675A3 Poly(beta-amino alcohols), their preparation, and uses thereof
05/10/2012WO2012027482A3 Compounds, compositions and methods related to ppar antagonists
05/10/2012WO2012027065A3 Combination therapy for treatment of disease
05/10/2012WO2012024637A3 Ethyl pyruvate compositions and methods
05/10/2012WO2012024478A3 Treatment of nicotinamide phosphoribosyltransferase (nampt) related diseases by inhibition of natural antisense transcript to nampt
05/10/2012WO2012022919A3 Nalbuphine-based formulations and uses thereof
05/10/2012WO2012021818A3 Ggf2 and methods of use
05/10/2012WO2012020021A9 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases
05/10/2012WO2012019430A8 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
05/10/2012WO2012019428A8 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof
05/10/2012WO2012019427A8 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
05/10/2012WO2012019426A8 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
05/10/2012WO2012019158A3 Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream
05/10/2012WO2012018932A3 Compounds and compositions for mitigating tissue damage and lethality
05/10/2012WO2012018383A3 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof
05/10/2012WO2012018377A3 Liposome targeting compounds and related uses
05/10/2012WO2012017325A3 Apparatus and process for encapsulating microparticles with liquid in soft gel capsules
05/10/2012WO2012016181A3 Anti-allergy lozenges
05/10/2012WO2012016139A3 Sirna compositions and methods for treatment of hpv and other infections
05/10/2012WO2012016081A3 Method and therapeutic for the treatment and regulation of memory formation
05/10/2012WO2012015249A3 Method for screening diabetes treating agent
05/10/2012WO2012012716A3 Targeting micrornas for the treatment of fibrosis
05/10/2012WO2012012656A3 Materials and methods for treating neurodegenerative diseases
05/10/2012WO2012012347A3 Methods of intravenous administration of glyburide and other drugs
05/10/2012WO2012010977A8 Single daily dosage form for prevention and treatment of metabolic syndrome
05/10/2012WO2012006612A3 Use of trans-palmitoleate in identifying and treating metabolic disease
05/10/2012WO2012006014A3 Multi-component pharmaceuticals for treating diabetes
05/10/2012WO2011156582A9 The use of inducible nitric oxide synthase inhibitors and nitric oxide scavengers to inhibit post-traumatic immunodepression
05/10/2012WO2011146819A3 METHODS AND COMPOSITIONS FOR TREATMENT NF-κB-MEDIATED AND α7 INTEGRIN-SUPPRESSED DISEASES
05/10/2012WO2011146624A9 Methods of treating recurring bacterial infection
05/10/2012WO2011146589A3 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles
05/10/2012WO2011139486A3 Layered drug delivery device
05/10/2012WO2011133889A3 NOVEL STRUCTURALLY DESIGNED shRNAs
05/10/2012WO2011130462A3 Intraocular pressure reduction with intracameral bimatoprost implants
05/10/2012WO2011127244A3 ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECT
05/10/2012WO2011120904A3 A fast dissolving pharmaceutical composition
05/10/2012WO2011116286A4 Stable bortezomib formulations
05/10/2012WO2011112875A3 Foamable formulation
05/10/2012WO2011110842A3 Inhibitors of glucose metabolism for use in the treatment of birt-hogg-dube syndrome
05/10/2012WO2011064271A4 Use of an oleo gel containing triterpene for healing wounds
05/10/2012WO2011031818A3 Histamine h3 inverse agonists and antagonists and methods of use thereof
05/10/2012WO2005117851A8 Prevention, treatment, and amelioration of radiation induced enteritis
05/10/2012US20120117674 Method for generating replication defective viral vectors that are helper free
05/10/2012US20120117672 Isolation and growth of stem cells from hemangiomas
05/10/2012US20120117671 Steatohepatitis-liver cancer model animal
05/10/2012US20120116360 Treatment of neurological disorders
05/10/2012US20120116287 Photolabile compounds
05/10/2012US20120116216 Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection
05/10/2012US20120116215 Deployment of polysaccharide markers for treating a site within a patient
05/10/2012US20120116052 Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 Domain
05/10/2012US20120115960 Animal feed compositions and feeding methods
05/10/2012US20120115959 Therapeutic Compositions And Methods
05/10/2012US20120115958 Liquid pharmaceutical formulation containing paracetamol
05/10/2012US20120115957 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
05/10/2012US20120115956 Use of isoleucine n-hexadecanoyl as a "volumizing" and/or "plumping" agent for human skin
05/10/2012US20120115955 Methods for tumor treatment and adipogenesis differentiation
05/10/2012US20120115954 Aqueous retinoid and benzoyl peroxide gel
05/10/2012US20120115951 Protective action of serofendic acid on cardiac muscle
05/10/2012US20120115950 Abuse-resistant amphetamine prodrugs
05/10/2012US20120115949 Ester Mixtures And Compositions Comprising Such Ester Mixtures
05/10/2012US20120115948 Inhibitors of anaphase promoting complex activity
05/10/2012US20120115947 Combination/association of adapalene and benzoyl peroxide for treating acne lesions
05/10/2012US20120115946 Formulation
05/10/2012US20120115945 Ferric citrate dosage forms
05/10/2012US20120115944 Use of carnitine and dihydroquercitin to positively influence the natural pigmentation process
1 ... 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 ... 7860